ENMD 0995
Alternative Names: S 3APGLatest Information Update: 04 Dec 2019
Price :
$50 *
At a glance
- Originator Celgene Corporation; Childrens Hospital Boston
- Class Antineoplastics; Phthalimides; Piperidones; Small molecules
- Mechanism of Action Angiogenesis inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Multiple myeloma